PubMed Health⌕ Search

Biomedical subjects

N M Khanna

Publications and source records attributed to N M Khanna.

14 recordsLinked to original sources
PubMed1991

Saponins from Deutzia corymbosa.

Two new saponins were isolated from Deutzia corymbosa and characterized as: echinocystic acid-3-O-[alpha-L-arabinopyranosyl(1----4)]alpha-L- arabinopyranoside and echinocystic acid-3-O-[beta-D-galactopyranosyl(1----4)alpha-L- rhamnopyranosyl(1----4)]alpha-L-arabinopyranoside. Umbellferone and sitosterol-beta-D-glucoside were also isolated and characterized.

Carbohydrate Sequence↗
PubMed1985

Evaluation of subdermal biodegradable implants incorporating rifampicin as a method of drug delivery in experimental tuberculosis of guinea pigs.

Conventional chemotherapy of tuberculosis and leprosy requires rifampicin to be administered orally. The long period of treatment and adverse side effects of the drug lead to poor compliance. To overcome this, subdermal implants incorporating rifampicin in pure and micro-encapsulated forms with biodegradable material were used as a new drug delivery system in experimental tuberculosis of guinea pigs. Two experiments were performed with 45-mg and 100-mg drug implants. Progress of infection was followed at intervals by studying necropsy scores and weights of the organs of predilection and levels of the drug in the blood were determined. There was a constant and sustained release of the drug in therapeutic concentrations for 30 and 50 days until the implants were completely assimilated without causing any damage to the implant site. The importance of multiple implants at long intervals is discussed.

Animals↗
PubMed1980

Isaptent--a new cervical dilator.

A new cervical dilator, Isaptent, was prepared from granulated Plantago ovata (Isapgol) seed husk. It was evaluated in a multicentric clinical trial for dilatation of the cervix in subjects opting for medical termination of pregnancy. The trial covered 804 women in over 21 centres in different parts of the country. The cases were between 15 to 45 years of age, 0 to 10 parity with a gestation period of 8 to 24 weeks. A single tent was used in 750 subjects and satisfactory dilatation was achieved in 94% of the cases. The cervical dilatation bore no relationship to age, parity and gestation period of the subjects. The tent provided self-lubrication, caused no apparent damage to the cervix and the vaginal flora remained unchanged in the randomly selected subjects in whom bacteriologic studies were performed. The outcome of the clinical trial and advantages of Isaptent over the other procedures used for cervical dilatation are discussed.

Abortion, Induced↗